Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 67, Issue 4, Pages -
Publisher
American Society for Microbiology
Online
2023-03-28
DOI
10.1128/aac.01703-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Valproate-coenzyme A conjugate blocks opening of receptor binding domains in the spike trimer of SARS-CoV-2 through an allosteric mechanism
- (2023) Federica Maschietto et al. Computational and Structural Biotechnology Journal
- Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19
- (2022) Julio Collazos et al. PLoS One
- Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review
- (2022) Sandra Runft et al. VETERINARY PATHOLOGY
- Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs
- (2022) Louis D Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
- (2022) Jessica Wagoner et al. Microbiology Spectrum
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
- (2021) Kris M. White et al. SCIENCE
- An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
- (2021) Omkar Indari et al. Frontiers in Pharmacology
- A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic
- (2021) Chris R. Triggle et al. Frontiers in Immunology
- Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
- (2021) Jiri Patocka et al. Pharmaceuticals
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
- (2021) Judith M. White et al. mBio
- Molnupiravir: A new candidate for COVID‐19 treatment
- (2021) Fariba Pourkarim et al. Pharmacology Research & Perspectives
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Clinical trials of repurposed antivirals for SARS-CoV-2
- (2020) Miguel Angel Martinez ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19
- (2020) Richard T. Eastman et al. ACS Central Science
- Efficacy of Remdesivir in COVID-19
- (2020) Erin K. McCreary et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
- (2020) Tesia Bobrowski et al. MOLECULAR THERAPY
- Successful treatment of hepatitis C virus infection with direct‐acting antivirals during hematopoietic cell transplant
- (2019) Hayley E. Cunningham et al. Transplant Infectious Disease
- Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
- (2019) Ariane J. Brown et al. ANTIVIRAL RESEARCH
- Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: Current incidence rates compared with rates during the interferon era
- (2019) Patrick Ingiliz et al. CLINICAL INFECTIOUS DISEASES
- Inhibition of Porcine Viruses by Different Cell-Targeted Antiviral Drugs
- (2019) Patricia de León et al. Frontiers in Microbiology
- Clinical Infections by Herpesviruses in Patients Treated with Valproic Acid: A Nested Case-Control Study in the Spanish Primary Care Database, BIFAP
- (2019) Gil et al. Journal of Clinical Medicine
- The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations
- (2018) José Maldonado et al. Viruses-Basel
- Interactions of lauryl gallate with phospholipid components of biological membranes
- (2016) Małgorzata Jurak et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial
- (2016) Lize Cuypers et al. INFECTION GENETICS AND EVOLUTION
- Inhibition of herpes virus infection in oligodendrocyte cultured cells by valproic acid
- (2016) A.J. Crespillo et al. VIRUS RESEARCH
- Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid
- (2013) Ángela Vázquez-Calvo et al. ANTIVIRAL RESEARCH
- Valproic Acid Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice
- (2013) Mu-huo Ji et al. INFLAMMATION
- The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase
- (2013) M. de Wispelaere et al. JOURNAL OF VIROLOGY
- Evaluation of Anti-herpetic and Antioxidant Activities, and Cytotoxic and Genotoxic Effects of Synthetic Alkyl-Esters of Gallic Acid
- (2012) Luciane Savi et al. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
- Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
- (2011) H.-H. Hoffmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The Hepatitis C Virus (HCV) NS4B RNA Binding Inhibitor Clemizole Is Highly Synergistic with HCV Protease Inhibitors
- (2010) Shirit Einav et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibition of Enveloped Virus Infection of Cultured Cells by Valproic Acid
- (2010) A. Vazquez-Calvo et al. JOURNAL OF VIROLOGY
- Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
- (2010) Tomoki Yoshikawa et al. PLoS One
- Structure–function studies for the panacea, valproic acid
- (2009) Nicole Terbach et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein
- (2009) Barbara Monti et al. NEUROTOXICITY RESEARCH
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started